Immunologic Factors: Clinical Trials

2 trials for Immunologic Factors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 11Unknown 1

Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Propranolol on Post Stroke Immune Status and Infection
Propranolol, Ceftriaxone - Stroke, Cerebrovascular Disorders
Phase 2UnknownTianjin Medical University General Hospital452022-06-012022-05-16
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12, Temozolomide - Glioblastoma, Glioma
Phase 1 / Phase 2UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine102020-12-012020-06-09

Narrower conditions

Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Infections (1)  ·  Ischemic Stroke (1)  ·  Neoplasms (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Nervous System Diseases (1)  ·  Neuroectodermal Tumors (1)  ·  Stroke (1)

Broader conditions

Astrocytoma (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Vascular Diseases (1)

Interventions

Ceftriaxone (1)  ·  Interleukin-12 (1)  ·  Propranolol (1)  ·  Temozolomide (1)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Tianjin Medical University General Hospital (1)

Countries

China (2)

Top investigators

Hong Shen, MD (1)